Brentuximab Intravenous and Mogamulizumab-kpkc Intravenous
Determining the interaction of Brentuximab Intravenous and Mogamulizumab-kpkc Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brentuximab
Brand name: Adcetris
Synonyms: Brentuximab vedotin, Brentuximab Vedotin
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brentuximab Intravenous-Molindone
- Brentuximab Intravenous-Mometasone (Oral Inhalation)
- Brentuximab Intravenous-Mometasone and Formoterol
- Brentuximab Intravenous-Mometasone and formoterol Inhalation
- Brentuximab Intravenous-Mometasone Cream
- Brentuximab Intravenous-Mometasone Furoate
- Mogamulizumab-kpkc Intravenous-Brentuximab vedotin
- Mogamulizumab-kpkc Intravenous-Breo Ellipta
- Mogamulizumab-kpkc Intravenous-Brethine
- Mogamulizumab-kpkc Intravenous-Brethine Subcutaneous
- Mogamulizumab-kpkc Intravenous-Bretylium
- Mogamulizumab-kpkc Intravenous-Bretylium Injection